GPT Healthcare IPO Review: Monday is the last day for public subscription of the initial public offering (IPO) of GPT Healthcare Limited. Today is a very important day for the potential subscribers of this IPO.
A substantial subscription rate of 85% was seen in the IPO on Friday, the second day of the IPO, which was launched on Thursday, 22 February. National Stock Exchange data showed that 1,67,51,920 bids were registered against 1,97,63,327 shares in the IPO. In the breakdown, retail individual investors (RIIs) subscribed 1.24 times, non-institutional investors garnered 79% share, and qualified institutional buyers garnered a 19% subscription rate.
GPT Healthcare IPO Review
The IPO of Kolkata-based GPT Healthcare is valued at ₹525 crore. This includes issuance of equity shares amounting to ₹40 crore and also an offer for sale (OFS) of 2.6 crore equity shares by private equity firm Banyantree Growth Capital.
According to a report, Banyantree currently holds 32.64% stake, which is equivalent to 2.6 crore shares. The price band for the IPO has been set at ₹177-186 per share. The funds raised from the IPO will be allocated to repay debt and for general corporate purposes.
Also read: GPT Healthcare IPO Subscription Status: IPO started, buy or not – read full information
GPT Healthcare IPO Review: GPT Healthcare was founded in the year 2000 by Dwarika Prasad Tantia, Om Tantia and Gopal Tantia. The company started with an eight-bed hospital in Kolkata. It now has four multispecialty hospitals with a combined capacity of 561 beds.
GPT Healthcare IPO Review: GPT Healthcare raised ₹157.54 crore from anchor investors in the initial IPO. A day before the public offering, the company allotted 84.7 lakh equity shares to 15 funds at ₹186 per share, which is the highest level of the defined price band.
(Note: This is not an investment advise; this article is just for information.)
